TrialAllergy2025

Subcutaneous Allergen Immunotherapy With Hypoallergenic Bet v 1 Compared to Conventional Extract: Poorer Blocking Antibody Capacity Dominated by IgG

Lorenz Aglas et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.